US Patent Issued to The Schepens Eye Research Institute on Feb. 25 for "Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors" (Massachusetts Inventors)

ALEXANDRIA, Va., Feb. 26 -- United States Patent no. 12,234,282, issued on Feb. 25, was assigned to The Schepens Eye Research Institute Inc. (Boston).

"Therapy for glaucoma and optic neuropathy by targeting colony stimulating factors" was invented by Dong Feng Chen (Newtonville, Mass.), Ji Min (Boston) and Kin-Sang Cho (Boston).

According to the abstract* released by the U.S. Patent & Trademark Office: "The invention provides compositions and methods for treating optic neuropathic disorders."

The patent was filed on May 16, 2023, under Application No. 18/318,336.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fsearch-...